NKE Factor-Based Stock Analysis

Validea's guru fundamental report indicates NIKE INC (NKE) receives an 88% rating based on Partha Mohanram's P/B Growth Investor model, which favors low book-to-market stocks exhibiting sustained growth characteristics. The model positively assesses Nike's book/market ratio, return on assets, cash flow from operations to assets, return on assets variance, sales variance, advertising to assets, and capital expenditures to assets, but the company fails the research and development to assets test. Mohanram's strategy, developed from academic research, identifies growth stocks likely to continue outperforming.

Analysis

Nike Inc. (NKE), a large-cap growth stock in the footwear industry, has garnered an 88% rating according to Validea's P/B Growth Investor model, based on Partha Mohanram's published strategy. This model identifies low book-to-market stocks with characteristics suggesting sustained future growth, and an 88% score signifies that the strategy has notable interest in NKE, falling between the 80% threshold for 'some interest' and short of the 90% for 'strong interest'. The company passed crucial tests within this framework, including its book/market ratio, return on assets, cash flow from operations to assets, the relationship between cash flow and return on assets, return on assets variance, sales variance, advertising to assets, and capital expenditures to assets. However, NKE did not meet the model's criterion for research and development to assets. Mohanram's academic-rooted methodology aims to differentiate successful growth stocks from underperformers by analyzing financial statement data.

Key Decisions for Investors

• Given Nike's 88% rating on the Partha Mohanram P/B Growth model, which signifies notable model interest, investors focused on growth strategies should consider this a positive fundamental signal for NKE.
• The specific failure to meet the research and development to assets criterion warrants closer scrutiny by investors, potentially indicating an area for deeper investigation regarding NKE's long-term innovation pipeline relative to its asset base.
• Investors may weigh the strong performance on multiple other financial health indicators, such as return on assets and robust cash flow metrics, against the R&D metric when assessing NKE's overall attractiveness as a growth investment.